Finoriq research workspace
PFIZER INC (PFE) SEC Filings & Filing Highlights
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical. Review PFE SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
- Company
- PFIZER INC (PFE)
- Ticker
- PFE
- Market Cap
- $141.3B
- Latest Price
- $24.79
- Industry
- Biotech & Pharma
PFIZER INC (PFE) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for PFIZER INC (PFE).
| Event | Form | Date |
|---|---|---|
| Among the factors that could cause actual results to differ materially from past results and fu...Following the disclosure of Pfizer’s Chief Financial Officer transition announcement on June 18, 2026, Pfizer today is reaffirming its fisc... | 8-K7.01 | 2026-06-18 |
| On June 16, 2026, Dave Denton notified Pfizer Inc. (the “Company”) that he will step down from...On June 16, 2026, Dave Denton notified Pfizer Inc. (the “Company”) that he will step down from his current position as Chief Financial Offi... | 8-K5.02 | 2026-06-18 |
| Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 GuidancePfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance | 8-K2.02 | 2026-05-05 |
| The Pfizer Inc. Annual Meeting of Shareholders was held on April 23, 2026(a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 23, 2026 | 8-K5.07 | 2026-04-27 |
| Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 GuidancePfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance | 8-K2.02 | 2026-02-03 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.